Probiotic BL-99 Cuts Gut Transit Time in Older Adults
A randomised trial finds probiotic BL-99 reduces whole-gut transit time in older adults by remodelling gut microbiota, with implications for UK gut health.
A specific probiotic strain — Bifidobacterium animalis subsp. lactis BL-99 — has been shown to significantly reduce whole-gut transit time and remodel gut microbiota composition in older adults, according to a randomised, double-blind clinical trial published in Nature. The findings, released on 6 October 2026, add to a growing body of UK microbiome research and international evidence linking probiotic interventions to meaningful improvements in gut motility with age.
Why This Matters
Age-related intestinal hypomotility — the slowing of gut movement that commonly affects older people — is a widespread but under-discussed concern for gut health in the UK. NHS data consistently identifies constipation and digestive sluggishness as significant quality-of-life issues in older adults, contributing to discomfort, medication use, and broader health complications. The gut-brain connection also means that poor gut motility can influence mood, cognition, and general wellbeing. Research into safe, targeted probiotic strategies to improve gut health naturally in ageing populations is therefore considered a clinical priority.
What the Trial Found
The randomised controlled trial, led by researchers at China Agricultural University and collaborating institutions, found that BL-99 intervention reduced whole-gut transit time — a key measure of how efficiently food moves through the digestive system — in older adult participants. Crucially, the study found that this effect was linked to remodelling of the gut microbiota, specifically through suppression of bile salt hydrolase-expressing bacterial species, according to the research team. This mechanistic detail suggests the probiotic reshapes the microbial environment in a targeted, functional way rather than producing only generalised changes.
What This Means for Readers
For health-conscious adults in the UK monitoring their gut health, the trial offers encouraging evidence that a specific probiotic strain — rather than broad dietary changes alone — may address age-related digestive slowing. While the British Dietetic Association and NHS guidelines already recommend fibre-rich diets and hydration to support gut motility, this study points toward probiotic supplementation as a complementary strategy worth discussing with a GP or registered dietitian. Further replication in UK cohorts would strengthen the case for clinical adoption.
The BL-99 trial represents a carefully controlled contribution to the rapidly expanding field of microbiome science. As UK microbiome research — including work from King's College London and the British Gut Project — continues to map how gut bacteria influence health across the lifespan, findings such as these reinforce the importance of the gut-brain axis and the potential to improve gut health naturally through evidence-based probiotic use in older populations.
You might also like
- Gut Microbiome Linked to Alzheimer's Stages in New Study
- 7 Gut-Brain Secrets That Could Transform Your Mood
- How to Improve Gut Health Naturally in 5 Steps
96 Bacterial Strains. Two Shots a Day.
GOODIE is an award-winning fermented drink with 96 live bacterial strains — more than any yogurt or kombucha — never pasteurised, clinically tested, and 8 in 10 users felt less bloating within 14 days. Curious?